- Article
 
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade
- Soong June Bae,
 - Jee Hung Kim,
 - Min Ji Lee,
 - Seung Ho Baek,
 - Yoonwon Kook,
 - Sung Gwe Ahn,
 - Yoon Jin Cha and
 - Joon Jeong
 
In patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, achievement of pathologic complete response (pCR) is a known prognostic indicator after neoadjuvant systemic therapy (NAST). We investigated the clinicopathologi...

